News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
586,254 Results
Type
Article (20994)
Company Profile (321)
Press Release (564931)
Multimedia
Podcasts (117)
Webinars (15)
Section
Business (195355)
Career Advice (447)
Deals (30119)
Drug Delivery (64)
Drug Development (71462)
Employer Resources (39)
FDA (12292)
Job Trends (10645)
News (286408)
Policy (22343)
Tag
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (3)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (7)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (7)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (1259)
Accelerated approval (43)
ADA (38)
Adcomms (17)
Allergies (151)
Alliances (41287)
ALS (217)
Alzheimer's disease (1522)
Antibody-drug conjugate (ADC) (554)
Approvals (12908)
Artificial intelligence (594)
ASCO (271)
Autoimmune disease (359)
Automation (41)
Bankruptcy (303)
Best Places to Work (8575)
BIO (65)
Biologics (4)
BIOSECURE Act (7)
Biosimilars (184)
BioSpace Insights (88)
Biotechnology (227)
Bispecific (1)
Bladder cancer (178)
Brain cancer (66)
Breast cancer (699)
Cancer (5660)
Cardiovascular disease (416)
Career advice (384)
Career pathing (14)
CAR-T (336)
CDC (8)
CDMO (97)
Celiac Disease (1)
Cell therapy (915)
Cervical cancer (43)
Clinical research (63717)
Collaboration (2077)
Commercialization (7)
Company closure (4)
Compensation (1604)
Complete response letters (76)
COVID-19 (1483)
CRISPR (126)
C-suite (1195)
Cystic fibrosis (145)
Data (8106)
Denatured (27)
Depression (164)
Dermatology (99)
Diabetes (504)
Diagnostics (4946)
Digital health (48)
Diversity (6)
Diversity, equity & inclusion (12)
Drug discovery (363)
Drug pricing (62)
Drug shortages (5)
Duchenne muscular dystrophy (330)
Earnings (81398)
Editorial (38)
Employer branding (6)
Employer resources (37)
Events (103930)
Executive appointments (1011)
FDA (15919)
Fibrodysplasia Ossificans Progressiva (10)
Fragile X (1)
Friedreich's ataxia (25)
Frontotemporal dementia (35)
Funding (1687)
Gene editing (264)
Generative AI (44)
Gene therapy (737)
GLP-1 (697)
Government (1831)
Grass and pollen (4)
Guidances (349)
Healthcare (12192)
Hematology (149)
HIV (71)
Huntington's disease (63)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (108)
Immunology and inflammation (286)
Immuno-oncology (104)
Indications (210)
Infectious disease (1749)
Inflammatory bowel disease (206)
Inflation Reduction Act (12)
Influenza (96)
Intellectual property (314)
Interviews (59)
IPO (14536)
IRA (14)
Job creations (2441)
Job search strategy (347)
JPM (41)
Kidney cancer (20)
Labor market (37)
Layoffs (323)
Leadership (15)
Legal (5672)
Licensing (21)
Liver cancer (67)
Longevity (33)
Lung cancer (777)
Lymphoma (410)
Machine learning (46)
Management (9)
Manufacturing (869)
Marketing (12)
MASH (197)
Medical affairs (1)
Medical device (9992)
Medtech (10164)
Mergers & acquisitions (16831)
Metabolic disorders (1260)
mRNA (200)
Multiple sclerosis (162)
Multispecific (1)
NASH (14)
Neurodegenerative disease (448)
Neuropsychiatric disorders (106)
Neuroscience (3074)
Neurotech (1)
NextGen: Class of 2026 (4158)
Non-profit (1587)
Now hiring (42)
Obesity (527)
Opinion (164)
Ovarian cancer (227)
Pain (235)
Pancreatic cancer (326)
Parkinson's disease (379)
Partnered (22)
Patents (604)
Patient advocacy (1)
Patient recruitment (797)
Peanut (55)
People (49776)
Pharmaceutical (50)
Pharmacy benefit managers (14)
Phase 1 (21023)
Phase 2 (28759)
Phase 3 (19548)
Pipeline (10036)
Policy (123)
Postmarket research (1900)
Preclinical (8972)
Press Release (53)
Prostate cancer (295)
Psychedelics (76)
Radiopharmaceuticals (352)
Rare diseases (1138)
Real estate (3805)
Recruiting (14)
Regulatory (19682)
Reports (37)
Research institute (1342)
Resumes & cover letters (61)
Rett syndrome (50)
RNA editing (32)
RSV (57)
Schizophrenia (177)
Series A (311)
Series B (224)
Service/supplier (5)
Sickle cell disease (119)
Special edition (21)
Spinal muscular atrophy (144)
Sponsored (23)
Startups (3147)
State (1)
Stomach cancer (8)
Supply chain (75)
Tariffs (21)
The Weekly (88)
Vaccines (594)
Venture capital (110)
Weight loss (269)
Women's health (107)
Worklife (3)
Date
Today (56)
Last 7 days (461)
Last 30 days (1890)
Last 365 days (25920)
2026 (17883)
2025 (26043)
2024 (30211)
2023 (34167)
2022 (43688)
2021 (45981)
2020 (41352)
2019 (30096)
2018 (22790)
2017 (24333)
2016 (22770)
2015 (29015)
2014 (24940)
2013 (20741)
2012 (22598)
2011 (22817)
2010 (22485)
Location
Africa (343)
Alabama (94)
Alaska (3)
Arizona (347)
Arkansas (14)
Asia (29277)
Australia (4502)
California (14012)
Canada (3815)
China (1373)
Colorado (571)
Connecticut (546)
Delaware (377)
Europe (55151)
Florida (2042)
Georgia (426)
Hawaii (4)
Idaho (47)
Illinois (949)
India (89)
Indiana (458)
Iowa (18)
Japan (562)
Kansas (116)
Kentucky (38)
Louisiana (43)
Maine (37)
Maryland (1494)
Massachusetts (10125)
Michigan (325)
Minnesota (648)
Mississippi (5)
Missouri (96)
Montana (32)
Nebraska (14)
Nevada (137)
New Hampshire (75)
New Jersey (3281)
New Mexico (19)
New York (3437)
North Carolina (1711)
North Dakota (9)
Northern California (7194)
Ohio (355)
Oklahoma (15)
Oregon (35)
Pennsylvania (2716)
Puerto Rico (25)
Rhode Island (38)
South America (542)
South Carolina (79)
South Dakota (1)
Southern California (5580)
Tennessee (150)
Texas (2245)
United States (47408)
Utah (408)
Vermont (1)
Virginia (250)
Washington D.C. (51)
Washington State (1139)
West Virginia (2)
Wisconsin (111)
Wyoming (1)
586,254 Results for "allos therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Allogene Therapeutics Announces Journal of Clinical Oncology Publication of Phase 1 Results of ALLO-316 Highlighting First Durable Remissions Following Allogeneic CAR T for Treatment of Metastatic Solid Tumors
July 15, 2026
·
10 min read
Press Releases
Allogene Therapeutics Announces Nature Communications Publication Highlighting Pre-Clinical Data for ALLO-329, a Next Generation Dual-Targeted CD19/CD70 Allogeneic CAR T for Autoimmune Diseases
April 15, 2026
·
8 min read
Press Releases
MiNK Therapeutics Reports New Data on agenT-797, an allo-iNKT Cell Therapy at ATS 2026; Simultaneously Published in Clinical Immunology Communications
May 20, 2026
·
6 min read
Press Releases
Allogene Therapeutics Announces Retirement of Chief Financial Officer Geoffrey Parker
September 2, 2026
·
1 min read
Press Releases
Allogene Therapeutics Announces Participation in September 2026 Investor Conference
August 31, 2026
·
2 min read
Press Releases
Allogene Therapeutics Reports Second Quarter 2026 Financial Results and Business Update
August 13, 2026
·
12 min read
Press Releases
Allogene Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update
August 4, 2026
·
2 min read
Press Releases
Allogene Therapeutics Announces Planned CEO Succession
May 29, 2026
·
7 min read
Press Releases
MiNK Therapeutics Presents New Data of allo-iNKT Cell Therapy as a Potential Disease-Modifying Approach in Idiopathic Pulmonary Fibrosis at Keystone Symposia
February 4, 2026
·
4 min read
Press Releases
MiNK Therapeutics and University of Wisconsin–Madison Announce Phase 1 Clinical Trial of Allo-iNKT Cell Therapy (AgenT-797) to Evaluate Prevention of Graft-Versus-Host Disease
January 9, 2026
·
7 min read
1 of 58,626
Next
